Status:
RECRUITING
Efficacy and Safety of Auto-FMT in Preventing aGVHD
Lead Sponsor:
The First Affiliated Hospital of Soochow University
Conditions:
Graft Versus Host Disease, Acute
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
To evaluation the efficacy and safety of autologous fecal bacteria transplantation in preventing acute graft versus host disease after haploidentical hematopoietic stem cell transplantation. Bone marr...
Eligibility Criteria
Inclusion
- Haplo-HSCT patients; Bacteroidetes \>0.1%; inverse Simpson diversity ≥2
Exclusion
- Gastrointestinal diseases；Age\>60; or Age\<10；Probiotics or prebiotics were taken before enrollment
Key Trial Info
Start Date :
March 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04745221
Start Date
March 1 2021
End Date
March 1 2026
Last Update
December 31 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ye Zhao
Suzhou, Jiangsu, China, 215006